DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

1.27 0.01 (0.79%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NAVB $1.27 0.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.25
Previous Close $1.26
Daily Range $1.25 - $1.31
52-Week Range $1.11 - $3.08
Market Cap $191.3M
P/E Ratio -3.60
Dividend (Yield) $0.00 (0.0%)
Volume 497,432
Average Daily Volume 522,902
Current FY EPS -$0.31

Sector

Healthcare

Industry

Healthcare Information Services

Navidea Biopharmaceuticals, Inc. (NAVB) Description

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians. Website: http://www.navidea.com/

News & Commentary

This Week in Biotech: Actions Speak Louder Than Words

Regulatory actions provided the impetus to big moves for these five biotech stocks.

Navidea Biopharmaceuticals (NAVB) Q2 2014 Results - Earnings Call Webcast

Navidea Joins Essex Woodland's Rheumco, Will Develop Radiopharmaceuticals To Detect And Treat Arthri

Navidea Joins Essex Woodland's Rheumco, Will Develop Radiopharmaceuticals To Detect And Treat Arthritic Diseases

Navidea Biopharmaceuticals' (NAVB) CEO Michael Goldberg on Investor Briefing on Sentinel Lymph Node

Navidea Biopharmaceuticals' (NAVB) CEO Michael Goldberg on Investor Briefing on Sentinel Lymph Node Biopsy in Head & Neck Cancers (Transcript)

Accuray Shows Continued Improvement - Analyst Blog

Cyberonics Poised on Favorable Market Trend - Analyst Blog

Thoratec Acquires Irish Implant Systems Maker - Analyst Blog

ABIOMED Acquires Germany's Medical Device Maker - Analyst Blog

Why Navidea Biopharmaceuticals Inc. Shares Briefly Spiked Lower

Navidea shares head the wrong way after a thumbs-up from the FDA.

Biotech Stock Mailbag: Vanda, Navidea, Provectus

See More NAVB News...

NAVB's Top Competitors

NAVB $1.27 (0.79%)
Current stock: NAVB
$0.00 (0.00%)
Current stock:
MDT $63.59 (-0.80%)
Current stock: MDT
COV $88.26 (-0.85%)
Current stock: COV